Industry News

Weekly Recap: FDA’s Active Proposal, Acquisitions and More

The top headlines on Happi between Dec. 7-13, 2025.

It should come as no surprise that our top-read headline this past week involved the words “FDA” and “bemotrizinol.” A new active ingredient for sunscreens in the US appears to be (finally) moving in the right direction.

Here’s a look at the top 8 most-accessed news headlines posted on Happi.com between Dec. 7-13, 2025:

FDA Proposes Adding Bemotrizinol as Permitted Active in Sunscreens

Gourmand Trend Gets Richer In 2026

Church & Dwight Sells Vitamin Brands, Manufacturing Sites

FDA Recalls Contaminated Baby Wash Kits

L’Oréal Increases Stake in Galderma

Faultless Brands Has a New Owner

NAD Shares Top Cases in Health & Wellness Advertising for 2025

Dr. Squatch Drops Stranger Things Collection Ahead of Season Finale

Maybelline New York Launches Grippy Serum Primer Campaign

Our Picks for the Week

In addition, here is a curated list of content from across Happi’s ecosystem that we don’t want you to miss.

IP @ Shiseido: Check out the Japanese beauty giant’s new patent related to inflammation.

Make This: Skincare chemists should check out this starting point formula for skin.

December Issue: This link takes you to our last issue of the year.

Keep Up With Our Content. Subscribe To Happi Newsletters